Search clinical trials for: PMC-403

Total 3877 results

Bridge Biotherapeutics, Inc.
Covance

Terminated

Efficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis

Ulcerative Colitis

New Zealand
Forte Biosciences, Inc.

Completed

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
pH Pharma

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects

Healthy Volunteer

United States
TWi Biotechnology, Inc.

Completed

A Double-blind, Intra-individual Comparison, POC Trial of AC-203 in EB Patients

Inherited Epidermolysis Bullosa

Taiwan
Simbec Research
Sensorion

Completed

A Study of SENS 401 in Healthy Subjects

Inner Ear Disease

United Kingdom
Cortendo AB

Completed

Levoketoconazole Food Effect Study in Healthy Subjects

Healthy Subjects

United States
Carl Zeiss Meditec AG

Completed

Clinical Safety and Efficacy of Hydrophilic Acrylic Intraocular Lenses (UVEA409)

Cataract

Sweden
Kyowa Kirin Co., Ltd.

Completed

The Phase II Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes; TSUBAKI Study

Type 2 Diabetes | Chronic Kidney Disease

Japan
Genus Oncology, LLC

Completed

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

Solid Tumors

United States
4SC AG

Completed

Single Dose Study With 4SC-203 in Healthy Volunteers

Acute Myeloid Leukemia

Germany
Ciusss de L'Est de l'Île de Montréal

Terminated

The Effect of Mitomycin C on Corneal Haze and Scarring After Corneal Crosslinking in Keratoconus Patients

Keratoconus

Canada
Mayo Clinic
National Cancer Institute (NCI)

Active, not recruiting

Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Melanoma | Metastatic Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Metastatic Melanoma

United States
Aeras
Crucell Holland BV

Completed

A Study to Evaluate the Safety of AERAS-402 in Adults Recently Treated for Pulmonary TB (C-010-402)

Tuberculosis

South Africa
University of Chicago

Completed

Study of MAGE-3/Melan-A/gp 100/NA17 and rhIL-12 With/Out Low Dose IL-2 in Metastatic Melanoma

Metastatic Melanoma

United States
Clexio Biosciences Ltd.

Recruiting

A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica

Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)

United States
Shanghai Yao Yuan Biotechnology Ltd. (also known...

Active, not recruiting

Evaluating the Safety, Tolerability, and Pharmacokinetics of DF-003 in Healthy Subjects

Healthy | Safety and Tolerability

United States
Reata, a wholly owned subsidiary of Biogen

No longer available

Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

Melanoma
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide in a Single Patient With Partial Lipodystrophy

Obesity | Hypertriglyceridemia

United States
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
ivWatch, LLC

Completed

Optical Detection of Intravenous Infiltration:A Pilot Study

Infiltration of Peripheral IV Therapy

United States
Boehringer Ingelheim

Completed

Safety of Total Daily Doses of Polyethylene Glycol (PEG) 400 Administered Orally to Healthy Male Human Subjects

Healthy
ivWatch, LLC

Completed

ivWatch Model 400: Device Validation for Non-Infiltrated Tissues

Infiltration of Peripheral IV Therapy

United States
Ono Pharmaceutical Co. Ltd

Completed

A Human Mass Balance Study to Determine the Total Recovery of Radioactivity in Urine and Faeces Following a Single Oral Dose of 14C Radiolabelled ONO-4053

Healthy Adult Male Subjects

United Kingdom
Ono Pharmaceutical Co. Ltd

Completed

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Healthy Adult Subjects

United Kingdom
Ono Pharmaceutical Co. Ltd

Terminated

A Phase I Study to Evaluate Safety, Tolerability and Pharmacokinetics of ONO-4053 in Healthy Volunteers

Healthy Adult Subjects

United Kingdom
GlaxoSmithKline

Completed

Bioavailability and Food Effect of the Original Gelatin Formulation and Two New Formulations of Afuresertib in Normal Healthy Volunteers

Cancer

Australia
Mayo Clinic

Recruiting

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia

Recurrent Chronic Myelomonocytic Leukemia | Refractory Chronic Myelomonocytic Leukemia

United States
Huahui Health

Completed

A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors

Chronic Hepatitis B

China
Tehran University of Medical Sciences
RojanPharma Pharmaceutical Company

Completed

Sofosbuvir and Daclatasvir for Treating Hepatitis C in 200 Patients Co-infected With Human Immunodeficiency Virus (HIV200)

Human Immunodeficiency Virus | Hepatitis C Virus Infection, Response to Therapy of

Iran, Islamic Republic of
Universität Duisburg-Essen

Recruiting

Craniosacral Therapy as a Self-help Strategy for Patients With Chronic Non-specific Back Pain (CRANIO4ME)

Low Back Pain, Mechanical | Complementary Therapies | Progressive Muscle Relaxation

Germany
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

MDS (Myelodysplastic Syndrome) | Severe Aplastic Anemia

United States
TuHURA Biosciences, Inc.

Available

IFx-Hu2.0 Expanded Access Program

Merkel Cell Carcinoma | Cutaneous Squamous Cell Carcinoma | Cutaneous Melanoma, Stage III | Cutaneous Melanoma, Stage IV
University of Washington
National Institute of Mental Health (NIMH); Harvard University

Completed

Kingasa Pilot Study

PrEP | HIV | PMTCT | Linkage to Care | ART Adherence

Uganda
Ina-Respond
National Institute of Health Research and Development, Ministry of Health... and other collaborators

Completed

Validation of POC-CCA Rapid Urine Test for Qualitative Detection of Schistosoma Japonicum (SchisCCA)

Aged ≥2 Years in Schistosomiasis Affected Areas

Indonesia
Spectral Diagnostics (US) Inc.

Temporarily not available

Open-label Evaluation of Polymyxin B Hemoperfusion for Septic Shock (EUPHORIA)

Septic Shock | Endotoxemia
Aga Khan University
Bill and Melinda Gates Foundation

Unknown

Implementation Research of Kangaroo Mother Care in Rural Pakistan. (KMC)

Low-Birth-Weight Infant

Pakistan
National Taiwan University Hospital

Completed

Endotoxin Adsorber Hemoperfusion and Microcirculation

Sepsis

Taiwan
Eli Lilly and Company

Completed

A Study of IMC-RON8 in Advanced Solid Tumors

Cancer

United States
Helsinki University Central Hospital

Withdrawn

PCC and Fibrinogen Compared With FFP in PPH

Postpartum Haemorrhage

Finland
O2 MedTech, Inc.
Duke University

Completed

Accuracy of the O2 MedTech PMS-3000 Monitor

Healthy

United States
Eli Lilly and Company

Completed

Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available

Solid Tumors

United States
Tenax Therapeutics, Inc.
Northwestern University; Medpace, Inc.

Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF (LEVEL)

Pulmonary Hypertension

United States
ICM Co. Ltd.

Enrolling by invitation

A Long Term Follow-up Study of Subjects Who Received ICM-203 or Matching Placebo

Osteoarthritis, Knee

Australia
Rhythm Pharmaceuticals, Inc.

Active, not recruiting

Long Term Extension Trial of Setmelanotide

Obesity Associated With Defects in Leptin-melanocortin Pathway

United States, Netherlands, Canada, Germany, United Kingdom, France, Greece, Spain
Marker Therapeutics, Inc.

Active, not recruiting

Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant (ARTEMIS)

Acute Myeloid Leukemia | Stem Cell Transplantation

United States
MEI Pharma, Inc.

Terminated

Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL)

Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)

United States, Spain, Korea, Republic of, Belgium, Taiwan, Germany, France, Italy, Australia, Poland, New Zealand, United Kingdom, Austria, Switzerland
Alpine Immune Sciences, Inc.

Completed

A Study of ALPN-303 in Adult Healthy Volunteers (RUBY-1)

Healthy Volunteers

Australia
Otonomy, Inc.

Completed

OTO-413 in Subjects With Speech-in-Noise Hearing Impairment

Sensorineural Hearing Loss

United States
pH Pharma

Completed

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects

Otherwise Healthy Overweight or Obese

United States
University of Kragujevac
Pharmanova d.o.o., Obrenovac, Serbia

Terminated

The Effects of One Month Consumption of Standardized Aronia Melanocarpa Extract on Anemia in Patients on Hemodialysis

Anemia | Renal Disease | Dialysis; Complications

Serbia

Search clinical trials for: PMC-403

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations